PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of EUR 6.26 billion. The enterprise value is 5.67 billion.

Market Cap	6.26B
Enterprise Value	5.67B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Aug 11, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	8.20%
Owned by Institutions (%)	8.70%
Float	295.60M

Valuation Ratios

The trailing PE ratio is 45.76 and the forward PE ratio is 28.97.

PE Ratio	45.76
Forward PE	28.97
PS Ratio	14.77
PB Ratio	7.22
P/TBV Ratio	7.27
P/FCF Ratio	68.58
P/OCF Ratio	43.74
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.69, with an EV/FCF ratio of 62.10.

EV / Earnings	41.44
EV / Sales	13.39
EV / EBITDA	39.69
EV / EBIT	42.53
EV / FCF	62.10

Financial Position

The company has a current ratio of 6.20, with a Debt / Equity ratio of 0.03.

Current Ratio	6.20
Quick Ratio	5.84
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.25
Interest Coverage	193.04

Financial Efficiency

Return on equity (ROE) is 16.97% and return on invested capital (ROIC) is 51.34%.

Return on Equity (ROE)	16.97%
Return on Assets (ROA)	9.00%
Return on Invested Capital (ROIC)	51.34%
Return on Capital Employed (ROCE)	15.06%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.24M
Profits Per Employee	1.04M
Employee Count	131
Asset Turnover	0.46
Inventory Turnover	1.29

Taxes

Income Tax	-1.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.76%
50-Day Moving Average	21.06
200-Day Moving Average	18.05
Relative Strength Index (RSI)	39.18
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of EUR 424.05 million and earned 136.84 million in profits. Earnings per share was 0.37.

Revenue	424.05M
Gross Profit	378.37M
Operating Income	133.67M
Pretax Income	135.15M
Net Income	136.84M
EBITDA	137.28M
EBIT	133.67M
Earnings Per Share (EPS)	0.37

Balance Sheet

The company has 615.50 million in cash and 23.22 million in debt, giving a net cash position of 592.28 million.

Cash & Cash Equivalents	615.50M
Total Debt	23.22M
Net Cash	592.28M
Net Cash Per Share	n/a
Equity (Book Value)	867.25M
Book Value Per Share	2.34
Working Capital	660.79M

Cash Flow

In the last 12 months, operating cash flow was 143.14 million and capital expenditures -51.84 million, giving a free cash flow of 91.31 million.

Operating Cash Flow	143.14M
Capital Expenditures	-51.84M
Depreciation & Amortization	3.61M
Net Borrowing	-6.21M
Free Cash Flow	91.31M
FCF Per Share	n/a

Margins

Gross margin is 89.23%, with operating and profit margins of 31.52% and 32.27%.

Gross Margin	89.23%
Operating Margin	31.52%
Pretax Margin	31.87%
Profit Margin	32.27%
EBITDA Margin	32.37%
EBIT Margin	31.52%
FCF Margin	21.53%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.02
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	7.26%
Buyback Yield	-0.13%
Shareholder Yield	-0.04%
Earnings Yield	2.19%
FCF Yield	1.46%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 22.46 and a Piotroski F-Score of 7.

Altman Z-Score	22.46
Piotroski F-Score	7